Clinical Trials
5 trialsNCT07623369 2026-06-03
A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors
Huahui Health
Phase 1 Not yet recruiting
NCT07623642 2026-06-03
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
GV20 Therapeutics
Phase 2 Not yet recruiting
NCT07272642 2026-02-25
DUNP19
Radiopharm Theranostics, Ltd
Phase 1 Not yet recruiting
NCT07246759 2025-11-24
NEUTROFLOW
OncoHost Ltd.
Not yet recruiting
NCT05698238 2023-03-15
CAMP1
Mabpro, a.s.
Phase 1 Not yet recruiting